🔎 Trials Near Me

Почетна › Рак дојке › Тексас › El Paso

Kliničke studije za Рак дојке u gradu El Paso, TX

7 studija za Рак дојке traži učesnike na lokacijama u gradu El Paso i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Тражи се учесникФаза 3
  • Renovatio Clinical - El Paso, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05894239

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • Texas Oncology - West Texas, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3
  • Texas Oncology-West Texas, El Paso
  • Texas Oncology-West Texas, El Paso
  • Texas Oncology-West Texas, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

Тражи се учесникФаза 3
  • Texas Oncology - West Texas, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07683754

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Тражи се учесникФаза 3
  • Research Site, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06103864

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Тражи се учесникФаза 3
  • Clinical Trial Site, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07085767

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Тражи се учесникФаза 2/3
  • Texas Oncology - West Texas, El Paso
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06926868

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu El Paso

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.